logo-loader
viewUniphar PLC

Uniphar to begin trading on AIM on 17 July with estimated £279mln market cap

The Irish pharmaceuticals wholesaler has also raised around £121.4mln (€135mln) in a share placing ahead of the float

Pharmaceuticals
Uniphar sells drugs to hospitals, pharmacies and clinics

Irish firm Uniphar PLC is to be admitted to AIM on 17 July with an expected market cap of around £279mln (€310mln).

The group, which distributes pre-wholesale and wholesale pharmaceuticals to hospitals, pharmacies and clinics, said it had also raised £121.4mln (€135mln) by issuing 117.4mln shares at a price of 103p (€1.15) each.

READ: Uniphar unveils plans for AIM float in July

The proceeds of the placing are to be used to fund the acquisition of Durbin, a specialist supplier of pharmaceuticals with offices in the UK and the US, as well as for general working capital and paying fees associated with the group’s initial public offering (IPO).

Maurice Pratt, Uniphar’s chairman, said that the level of interest from institutional investors for the IPO gave the company “great confidence” in its next phase of growth as a public company.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

NQ Minerals' David Lenigas focused on restructuring debt and upping profits...

NQ Minerals PLC's (LON:NQMI) David Lenigas speaks to Proactive London's Andrew Scott soon after taking over as chairman at the Australia-focused mining group. Production and exploration plans aside, Lenigas also says they're in advanced talks to replace on more favourable terms all the debt...

12 hours, 44 minutes ago

2 min read